Torrent Pharmaceuticals Board of Directors

Get the latest insights into the leadership at Torrent Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Sudhir Mehta Chairman Emeritus
Mr. Samir Mehta Executive Chairman
Mr. Aman Samir Mehta Whole Time Director
Mr. Jinal Mehta Non Executive Director
Mr. Manish Mahendra Choksi Independent Director
Mr. Nikhil Khattau Independent Director
Ms. Ameera Shah Independent Director
Ms. Nayantara Bali Independent Director

Torrent Pharmaceuticals Share price

TORNTPHARM

3559.8

17.10 (-0.48%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:40 IST
BUYSELL
Today's High

3607.60

Today's Low

3553.30

52 Week Low

2886.45

52 Week High

3787.90

The current prices are delayed, login to your account for live prices

Torrent Pharmaceuticals FAQs

The board at Torrent Pharmaceuticals consists of experienced professionals, including Mr. Sudhir Mehta , Mr. Samir Mehta , and others, overseeing the company’s strategic and corporate governance.

Directors at Torrent Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Sudhir Mehta is the current chairman at Torrent Pharmaceuticals.

Executive directors at Torrent Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Torrent Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Torrent Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.